Skip to main content
TipRanks
Go Ultimate75% OFF

Matthew Plooster Insider Profile

4 Followers

Matthew Plooster, Director at Zevra Therapeutics, holds 20.10K shares in Zevra Therapeutics (Ticker: ZVRA). Most recently, Matthew Plooster Bought 11,000 shares of Zevra Therapeutics on Mar 13, 2023 for an estimated value of $46.09K.

Matthew Plooster's Trading History

ZVRA
Zevra Therapeutics
Mar 13, 2023DirectorInformative Buy46.09K$185.93K
ZVRA
Insider Shares: 20.10K (0.06%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 13, 2023Informative Buy$46.09K11,000$4.19+41.40%
May 18, 2022Informative Buy$24.78K5,000$4.95+6.00%
Dec 01, 2021Uninformative Buy$21.10K2,500$8.44―
Jul 02, 2019Uninformative Buy$0.007,857$0.00―
May 14, 2019Uninformative Buy$0.008,487$0.00―

You May Also Like

Matthew Plooster insider profile FAQ

What is the percentage of profitable transactions made by Matthew Plooster?
The percentage of profitable transactions made by Matthew Plooster is 67%.
What is the average return per transaction made by Matthew Plooster?
The average return per transaction made by Matthew Plooster is -8.40%.
What stocks does Matthew Plooster hold?
Matthew Plooster holds: ZVRA stocks.
What was Matthew Plooster’s latest transaction?
Matthew Plooster’s latest transaction was an Informative Buy of $46.09K.
What was Matthew Plooster's most profitable transaction?
Matthew Plooster’s most profitable transaction was an Informative Buy of ZVRA stock on March 13, 2023. The return on the trade was 41.40%.
What is Matthew Plooster's role in Zevra Therapeutics?
Matthew Plooster's role in Zevra Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.